Anti-Snoring Devices Market Size, Share & Trends Analysis Report By Product Type (Oral Appliances, Nasal Devices, Continuous Positive Airway Pressure (CPAP) Devices, Chin Straps, Position Control Devices, Smart Anti-Snoring Devices, Others (e.g., Anti-Snoring Pillows)), By Distribution Channel (Online Retail, Hospital Pharmacies, Retail Pharmacies, Clinics, Others (e.g., Speciality Stores)), By End User (Homecare, Hospitals, Sleep Clinics, Others (e.g., Research Institutes)) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Anti-Snoring Devices Market Size

The global anti-snoring devices market size was valued at USD 1.38 billion in 2024 and is projected to grow from USD 1.49 billion in 2025 to USD 2.74 billion in 2033, exhibiting a CAGR of 7.92% during the forecast period (2025-2033).

The global anti-snoring devices market is witnessing robust growth, driven by the increasing prevalence of sleep disorders, particularly obstructive sleep apnea (OSA), and rising awareness of snoring-related health risks, such as cardiovascular issues and sleep deprivation. The growing obese and ageing populations and technological advancements in non-invasive devices like mandibular advancement devices (MADs) and nasal dilators drive market growth. Trends such as smart anti-snoring devices with sensors and AI integration are gaining traction, enhancing user comfort and compliance.

North America dominates due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising disposable incomes and healthcare investments. The market faces challenges like high device costs and limited awareness in low-income areas, but it is supported by innovations and e-commerce accessibility. Strategic partnerships and product launches by key players further propel growth, addressing the needs of millions affected by snoring globally.

Market Trends

Rise of smart anti-snoring devices

A prominent trend in the anti-snoring devices market is the rise of smart devices integrated with sensors, AI, and mobile connectivity, offering personalised solutions for snoring management. These devices monitor sleep patterns, adjust interventions in real-time, and provide data-driven insights via apps, improving user compliance and effectiveness. Smart features, like vibration pulses to tense jaw muscles, enhance airflow and reduce snoring. The trend is driven by consumer demand for non-invasive, tech-driven solutions and increasing smartphone penetration.

• For instance, in January 2024, DeRucci unveiled its AI Series T11 Pro Smart Mattress line, which includes features like anti-snore pillows and intelligent height-adjustable pillows as part of its AI IoT line.

This trend supports market growth by addressing OSA, affecting nearly 1 billion people globally, per a 2024 Journal of Clinical Medicine study, and aligns with the shift toward home-based healthcare.

Anti-Snoring Devices Market Growth Factor

Increasing prevalence of obesity and sleep apnea

The rising prevalence of obesity and obstructive sleep apnea (OSA) is a major driver of the anti-snoring devices market. OSA, a severe sleep disorder, impacts nearly 1 billion individuals, as reported by a 2024 Journal of Clinical Medicine study, significantly elevating risks of serious health complications such as cardiovascular diseases, hypertension, and stroke. This dire health burden intensifies the demand for effective non-invasive solutions like mandibular advancement devices (MADs) and continuous positive airway pressure (CPAP) devices.

• For example, in May 2024, Glidewell announced the launch of its fully digital, 3D-printed Silent Nite® 3D Sleep Appliance, designed for a precise and comfortable fit to alleviate snoring and mild to moderate OSA. This release highlights the growing demand for such oral appliances.

Awareness campaigns, such as those by the National Sleep Foundation, and favourable reimbursement policies in North America further fuel adoption. The growing ageing population, with 25% of U.S. adults snoring routinely, amplifies the need for effective anti-snoring solutions.

Market Restraining Factor

High costs and limited awareness in low-income regions

The anti-snoring devices market faces significant restraints from the high costs of advanced devices and a pervasive lack of awareness, particularly in low- and middle-income regions. Sophisticated devices such as CPAP machines and custom-fitted MADs often carry substantial price tags, frequently exceeding USD 1,000, thereby creating a considerable barrier to accessibility for budget-constrained consumers. Compounding this challenge are widespread misconceptions about the potential health risks associated with snoring and a limited understanding of the effectiveness of available devices, especially in areas like parts of Latin America and Africa.

Furthermore, the prerequisite for specialised sleep studies for accurate diagnosis, which can incur costs ranging from USD 1,500 to USD 3,000, introduces additional financial hurdles. In regions with underdeveloped healthcare infrastructures, exemplified by sub-Saharan Africa, where as few as 10% of OSA cases are diagnosed according to a 2022 European Respiratory Society study, these factors severely restrict market expansion and slow growth, despite the global demand for non-invasive solutions.

Market Opportunity

Technological advancements in customisable devices

Technological advancements in customisable anti-snoring devices present significant market opportunities, driven by innovations like 3D printing and AI-driven personalisation. These technologies enhance device comfort and efficacy, addressing consumer demand for non-invasive solutions.

• For example, in January 2024, SnoreLessNow launched its FDA-cleared Anti-Snore Mouth Guard+, developed in collaboration with Oscimed SA, leveraging 3D digital scanning to produce perfectly tailored oral appliances. This innovation dramatically improves airflow and significantly enhances obstructive sleep apnea (OSA) management, showcasing the power of precision manufacturing.
• Similarly, in April 2024, Smartee Dental Technology introduced its innovative S8 aligners, which ingeniously combine mandibular advancement capabilities with traditional tooth alignment, offering a revolutionary dual-purpose treatment for even severe malocclusion.

These advancements align with the growing preference for home-based, user-friendly devices, supported by rising disposable incomes in Asia-Pacific. Government initiatives further boost access to advanced devices, driving market scalability and adoption in high-prevalence regions.

Regional Insights

North America leads the anti-snoring devices market due to its advanced healthcare infrastructure and widespread awareness of sleep-related disorders. The region benefits from strong public and private investment in sleep research and innovation, along with the presence of major market players consistently launching technologically advanced solutions. Consumer demand for non-invasive, home-based treatments is growing, driven by rising health consciousness and telemedicine adoption. Supportive reimbursement policies, public education campaigns, and high healthcare accessibility further encourage the use of anti-snoring devices. Additionally, the prevalence of lifestyle-related conditions and an ageing population contribute to increased demand for personalised and easy-to-use sleep aids, reinforcing the region’s dominance in the market.

U.S. Anti-Snoring Devices Market Trends

The U.S. market is driven by widespread awareness of sleep disorders and a well-established healthcare infrastructure. Rising rates of obesity and ageing are contributing to increased cases of snoring and obstructive sleep apnea, which, in turn, drive demand for non-invasive solutions like oral appliances. Government funding supports innovation and research in sleep health, while private companies continue launching advanced, tech-enabled devices. Additionally, e-commerce platforms make it easier for consumers to access devices directly, while leading players continually expand their product lines to meet evolving consumer needs.

Canada’s anti-snoring devices industry is expanding due to greater public education around sleep health and growing demand for user-friendly homecare solutions. Increased healthcare investments support the distribution and accessibility of treatment devices, particularly for sleep apnea. Innovations in device design, especially around comfort and ease of use, are helping attract first-time users. The adoption of telehealth and remote diagnostics supports home-based treatment. Online retail and urban-focused health infrastructure are also improving product accessibility and contributing to consistent market growth.

Asia-Pacific Anti-Snoring Devices Market Trends

Asia-Pacific is the fastest-growing region in the market, propelled by economic development, rising healthcare awareness, and improving access to medical technologies. Urbanisation and sedentary lifestyles have led to a growing burden of sleep disorders, fueling the need for effective snoring management solutions. Consumers increasingly seek affordable, convenient devices that can be used at home without medical supervision. Growth in e-commerce platforms has made these products more accessible across urban and semi-urban areas. Government-led health campaigns and increased healthcare spending encourage the use of non-invasive therapies. Innovation from regional manufacturers is also expanding the availability of customised and multi-functional devices, making the region highly dynamic and promising for future expansion.

China’s anti-snoring device market is rapidly growing due to increasing urbanisation, healthcare spending, and awareness of sleep disorders. A growing middle class with higher disposable income is driving demand for modern, non-invasive treatments. Government investments in sleep health programs promote awareness and facilitate access to devices. With the popularity of e-commerce platforms, companies can directly reach large customer bases across major cities and emerging regions. Additionally, lifestyle changes contributing to obesity and poor sleep hygiene are increasing the need for effective anti-snoring solutions.

India’s market growth is driven by expanding healthcare infrastructure, rising public awareness of sleep apnea, and increasing investment in sleep-related diagnostics and treatments. Urban populations are embracing advanced oral appliances and nasal devices, supported by targeted health campaigns. The rise of e-commerce platforms is improving access, especially among young professionals seeking affordable and convenient options. Domestic manufacturers are launching cost-effective products to address both snoring and lifestyle-related disorders. Supportive government policies and income growth further enhance market potential.

Europe Anti-Snoring Devices Market Trends

Europe’s growth in the market for anti-snoring devices is driven by a strong focus on preventive healthcare, early diagnosis, and high consumer awareness of sleep health. The region benefits from robust healthcare infrastructure, public insurance systems, and an ageing population increasingly seeking non-invasive snoring solutions. Leading European companies continue introducing advanced oral and wearable devices, supported by strong medical research and development investments. Public health initiatives encourage better sleep hygiene, while established distribution channels, including pharmacies and online platforms, improve device accessibility. Additionally, rising consumer interest in home-based treatments and comfort-oriented technologies fosters the adoption of customisable, easy-to-use products across the region.

Germany’s anti-snoring devices market benefits from a highly developed healthcare system, strong government support for medical research, and a population prioritising health and wellness. The country has a solid foundation for diagnosing and treating sleep-related disorders, encouraging the use of advanced solutions like mandibular advancement devices and smart wearables. Companies leverage Germany’s medical infrastructure to distribute personalised and comfortable devices. With increased public and private investment in sleep health and growing interest in homecare solutions, demand for non-invasive snoring treatments continues to rise steadily.

France’s market is driven by government-backed innovation in medical technology, rising awareness of sleep disorders, and growing consumer demand for non-invasive treatments. Healthcare initiatives and strategic partnerships between manufacturers and local clinics have improved access to advanced oral appliances. Consumers increasingly favour home-use devices such as nasal dilators and smart sensors. Health campaigns and educational efforts from professional associations further boost awareness. The country's commitment to supporting digital health and expanding e-commerce enhances the visibility and distribution of anti-snoring devices.

Product Type Insights

Oral appliances, particularly mandibular advancement devices (MADs), dominate the market, holding a 38% revenue share in 2024. These oral appliances reposition the lower jaw to keep the airway open, offering a non-invasive and effective solution for mild to moderate obstructive sleep apnea (OSA). The increasing awareness of snoring’s link to serious health risks such as heart disease and stroke further supports market growth. Favourable insurance reimbursement policies, especially in North America, support adoption. Furthermore, the growing ageing population and obesity epidemic increase demand for custom-fit MADs, often made using 3D printing. With rising interest in home-based and wearable health tech, MADs continue to dominate the product segment of this growing market.

Distribution Channel Insights

Online retail leads the distribution channel segment with a 42% share in 2024, driven by the ease of direct-to-consumer (DTC) shopping and a growing preference for e-commerce. With smartphone penetration and digital health platforms expanding, consumers increasingly turn to online channels for FDA-cleared, home-delivered anti-snoring devices. Online stores also offer competitive discounts, subscription models, and access to customer reviews, especially appealing to tech-savvy users in North America and Europe. Awareness campaigns and influencer marketing help build trust, while home delivery and return options further simplify the buying process. The online segment benefits especially from the rising popularity of smart anti-snoring devices, allowing users to purchase tailored solutions without medical visits and supporting market expansion.

End User Insights

The homecare segment dominates the end-user landscape, capturing 55% of the market in 2024, due to the increasing demand for non-invasive, self-managed snoring solutions. Many prefer managing snoring and mild sleep apnea from home using mandibular devices, nasal dilators, or wearable smart tech. As healthcare costs rise globally, homecare devices offer cost-effective alternatives to clinical treatments like CPAP. Ageing populations and higher awareness of snoring’s health impacts contribute to demand. In developed regions, especially the U.S. and Europe, the trend is also supported by reimbursement programs and the desire for privacy and convenience in managing sleep disorders, making home care the fastest expanding end-user segment.

Company Market Share

Key players in the anti-snoring devices market focus on innovation, launching smart, non-invasive devices like MADs and CPAP machines with AI and Bluetooth connectivity. Strategic partnerships with healthcare providers and e-commerce platforms expand reach. Companies invest in R&D to improve comfort and efficacy, targeting homecare users. Acquisitions and regional expansions, particularly in Asia-Pacific, enhance market share. Sustainability and regulatory compliance are priorities, with firms developing compact, user-friendly solutions to meet growing demand.

ResMed: ResMed is a market leader, leveraging its expertise in sleep apnea solutions to dominate the anti-snoring devices market. The company focuses on innovative CPAP devices and oral appliances, integrating smart connectivity for real-time monitoring. Strategic collaborations with healthcare providers and global distribution networks drive its 20% market share in 2024. ResMed’s R&D investments, targeting compact and user-friendly designs, fuel growth, with a projected 10% revenue increase by 2033. Its focus on homecare solutions aligns with consumer trends, enhancing adoption.

Latest News

• In April 2024, ResMed introduced the AirMini AutoSet, a compact, travel-friendly CPAP device with advanced connectivity, improving patient compliance for snoring and OSA treatment. This launch strengthens ResMed’s position in the homecare segment, addressing the rising demand for portable solutions.

Recent Developments

• January 2025- SnoreLessNow expanded its FDA-cleared Anti-Snore Mouth Guard+ to Europe, leveraging 3D scanning for personalised MADs. This move targets Germany and France, capitalising on high OSA prevalence and e-commerce growth. The device’s comfort and efficacy strengthen SnoreLessNow’s position in the homecare segment, supporting market growth in tech-driven regions.
• October 2024- Philips Respironics launched DreamMapper, a cloud-based platform enabling users to track sleep therapy data and connect with healthcare providers. This enhances compliance for CPAP and MAD users, addressing snoring and OSA. The platform’s integration with smart devices boosts Philips’ market presence in North America and Europe, aligning with the trend toward data-driven healthcare solutions.